DAMAI ENT Surges Over 4% Intraday, Poised to Fully Benefit from Consumption Structure Upgrade

Deep News
01/20

DAMAI ENT (01060) rose more than 4% during the trading session. As of the time of writing, the stock was up 3.26%, trading at HK$0.95 with a turnover of HK$99.4266 million.

Recently, at the 2025 Annual Meeting of the Exhibition Exchange Professional Committee of the Chinese Museum Association held in Hangzhou, the China Cultural Heritage Exchange Center, in collaboration with DAMAI ENT's "Yi Zhan Hong Tu" and the cultural museum service provider "Zhong Chuang Yun Qi," jointly launched the "Cultural Context Integration, Digital Intelligence Advancement - Launch Plan," also known as the 2026 Museum "Special Exhibition Cooperation Plan." This initiative aims to partner with museums across China to create innovative cultural museum special exhibition projects. This marks DAMAI ENT's first invitation to participate in the conference, signaling its official entry into the museum sector. Moving forward, DAMAI ENT plans to deepen its collaboration with museums across three key areas: exhibition marketing, content production, and ticketing systems.

CITIC Securities points out that DAMAI ENT's IP business is performing strongly. Domestically, its performance business is expected to benefit from policy changes, while internationally, it stands to gain from the implementation of hosted projects. Furthermore, the company is anticipated to have significant involvement in both production and distribution during the 2026 Spring Festival season.

Previously, Western Securities indicated that the company is well-positioned in two high-growth sectors: live performances and IP derivatives. Its ticketing business provides a stable fundamental base, and Alibaba Fish is expected to contribute earnings elasticity, allowing the company to fully benefit from the ongoing recovery and structural upgrade in offline entertainment consumption.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10